Role of Insulin Resistance in MAFLD.
Role of Insulin Resistance in MAFLD.
复制标题
胰岛素抵抗在MAFLD中的作用
DOI:
10.3390/ijms22084156
复制
发表时间:
2021-04-16
影响因子:
5.6
通讯作者:
Kadowaki T
中科院分区:
文献类型:
--
作者:
Sakurai Y;Kubota N;Yamauchi T;Kadowaki T
Many studies have reported that metabolic dysfunction is closely involved in the complex mechanism underlying the development of non-alcoholic fatty liver disease (NAFLD), which has prompted a movement to consider renaming NAFLD as metabolic dysfunction-associated fatty liver disease (MAFLD). Metabolic dysfunction in this context encompasses obesity, type 2 diabetes mellitus, hypertension, dyslipidemia, and metabolic syndrome, with insulin resistance as the common underlying pathophysiology. Imbalance between energy intake and expenditure results in insulin resistance in various tissues and alteration of the gut microbiota, resulting in fat accumulation in the liver. The role of genetics has also been revealed in hepatic fat accumulation and fibrosis. In the process of fat accumulation in the liver, intracellular damage as well as hepatic insulin resistance further potentiates inflammation, fibrosis, and carcinogenesis. Increased lipogenic substrate supply from other tissues, hepatic zonation of Irs1, and other factors, including ER stress, play crucial roles in increased hepatic de novo lipogenesis in MAFLD with hepatic insulin resistance. Herein, we provide an overview of the factors contributing to and the role of systemic and local insulin resistance in the development and progression of MAFLD.
登录
查看更多内容
DOI:
10.1002/hep.29273
发表时间:
2017-10
期刊:
Hepatology (Baltimore, Md.)
影响因子:
--
作者:
BasuRay S;Smagris E;Cohen JC;Hobbs HH
通讯作者:
Hobbs HH
影响因子:
7.7
作者:
Cani, Patrice D.;Amar, Jacques;Burcelin, Remy
通讯作者:
Burcelin, Remy
影响因子:
7.7
作者:
Boden, G;She, PX;Ruderman, N
通讯作者:
Ruderman, N
影响因子:
6.5
作者:
Brown, J. Mark;Betters, Jenna L.;Yu, Liqing
通讯作者:
Yu, Liqing
影响因子:
5.6
作者:
Chang ML;Yang Z;Yang SS
通讯作者:
Yang SS